AISAP Cardio vs qXR-CTR
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if your clinical setting requires immediate, comprehensive cardiac diagnostic assessments at the point of care using ultrasound. This tool is ideal for detailed evaluations of structural heart disease, valvular pathologies, and precise measurements like Left Ventricle Ejection Fraction (LVEF), enabling early and thorough detection of cardiac conditions.
View AISAP Cardio →Choose qXR-CTR if…
Choose qXR-CTR if your primary need is automated, rapid assessment of heart size and potential heart failure risk directly from chest X-ray images. This solution is particularly well-suited for initial screening in high-volume environments or when a quick, non-invasive indicator of cardiac enlargement is needed without requiring a full echocardiogram.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | qXR-CTR |
|---|---|---|
| Deployment | Cloud-based | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed for point-of-care ultrasound (POCUS) at the bedside, implying a strong focus on intuitive interfaces for rapid use by clinicians, including non-specialists. Its integration with existing clinical workflows, EHR/EMR, and PACS further enhances its practical usability in diverse healthcare settings.
Clinical Value
AISAP CardioAISAP Cardio offers a comprehensive suite of cardiac diagnostic assessments, including LVEF, ventricular dimensions, atrial areas, and valvular pathologies, enabling early detection of structural heart disease and heart failure. In contrast, qXR-CTR focuses on a single measurement: the cardiothoracic ratio from chest X-rays, providing a more limited scope of clinical utility.
Pricing & Value
TieBoth AISAP Cardio and qXR-CTR have non-publicly disclosed pricing, requiring direct contact for information. Without transparent pricing details for either product, it is impossible to conduct a meaningful comparison of their respective value propositions.
Enterprise Readiness
qXR-CTRqXR-CTR explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), alongside flexible deployment options including cloud, on-premise, and hybrid. While AISAP Cardio is FDA-cleared and likely compliant, qXR-CTR's explicit statements and deployment versatility indicate a higher degree of demonstrated enterprise readiness.
Innovation
AISAP CardioAISAP Cardio's application of AI to point-of-care ultrasound for comprehensive, real-time cardiac diagnostic assessments at the bedside represents a significant innovation in expanding diagnostic capabilities for a broader range of clinicians. qXR-CTR, while valuable, offers a more focused automation of a single measurement (CTR) from chest X-rays.
Support & Docs
TiePublicly available information regarding specific support structures, service level agreements, or detailed documentation portals for either AISAP Cardio or qXR-CTR is not readily accessible. Both companies primarily direct users to contact them for more information, making a direct comparison of their support and documentation offerings unfeasible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | qXR-CTR |
|---|---|---|
| Name | AISAP Cardio | qXR-CTR |
| Company | Aisap | Qure.ai Technologies |
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology, Radiology |
| Key Features | AI-powered interpretation for early cardiac disease detection; Comprehensive cardiac ultrasound software package; Automated generation of analyses, interpretations, and reports; Assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis); Measurement of Left Ventricle Ejection Fraction (LVEF); Measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter; Vendor-agnostic and scalable solution; Integration with existing clinical workflows, EHR/EMR, and PACS | Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and qXR-CTR.